Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityActive in the last 2 years

Zhe Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9525-035X; OpenAlex author ID A5017746300. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1186/s12885-024-12005-2↗
  2. ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis. Co-author DOI 10.3389/fmolb.2021.764900↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shanyu Qin · 1 shared paper, 2024 · strength 0.26
  2. Chenming Ni · 1 shared paper, 2021 · strength 0.12
  3. Shuwen Han · 1 shared paper, 2021 · strength 0.12
  4. Xu Dong Sun · 1 shared paper, 2021 · strength 0.12
  5. Qiang Yan · 1 shared paper, 2021 · strength 0.12
  6. Weilin Wang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.